loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Prestwick3_001020 NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Aspen Oss B.V. (1)

filter

01 Rimexolone (1)

filter

01 Netherlands (1)

Rimexolone
POWDER (1g/g)
BULK INGREDIENT
60870-0423
1997-05-29
2024-12-31

Looking for 49697-38-3 / Rimexolone API manufacturers, exporters & distributors?

Rimexolone manufacturers, exporters & distributors 1

41

PharmaCompass offers a list of Rimexolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rimexolone manufacturer or Rimexolone supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rimexolone manufacturer or Rimexolone supplier.

PharmaCompass also assists you with knowing the Rimexolone API Price utilized in the formulation of products. Rimexolone API Price is not always fixed or binding as the Rimexolone Price is obtained through a variety of data sources. The Rimexolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Rimexolone

Synonyms

Vexol, 49697-38-3, Rimexolon, Org-6216, Org 6216, Mls002154105

Cas Number

49697-38-3

Unique Ingredient Identifier (UNII)

O7M2E4264D

About Rimexolone

Rimexolone is a derivative of prednisolone, a synthetic glucocorticoid with anti-inflammatory and immunosuppressive property. Upon binding to the cytosolic glucocorticoid receptor and cell entry, rimexolone activates specific glucocorticoid response elements, resulting in altered gene expression. These include induction of synthesis of anti-inflammatory protein IkappaB-alpha and inhibition of synthesis of nuclear factor kappaB (NFkappa B). As a result, pro-inflammatory cytokine production such as interleukin-1 (IL-1), IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved.

Prestwick3_001020 Manufacturers

A Prestwick3_001020 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prestwick3_001020, including repackagers and relabelers. The FDA regulates Prestwick3_001020 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prestwick3_001020 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Prestwick3_001020 Suppliers

A Prestwick3_001020 supplier is an individual or a company that provides Prestwick3_001020 active pharmaceutical ingredient (API) or Prestwick3_001020 finished formulations upon request. The Prestwick3_001020 suppliers may include Prestwick3_001020 API manufacturers, exporters, distributors and traders.

click here to find a list of Prestwick3_001020 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Prestwick3_001020 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Prestwick3_001020 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Prestwick3_001020 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Prestwick3_001020 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Prestwick3_001020 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Prestwick3_001020 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Prestwick3_001020 suppliers with NDC on PharmaCompass.

Prestwick3_001020 Manufacturers | Traders | Suppliers

Prestwick3_001020 Manufacturers, Traders, Suppliers 1
18

We have 1 companies offering Prestwick3_001020

Get in contact with the supplier of your choice:

  1. Aspen API
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY